Empagliflozin attenuates doxorubicin-impaired cardiac contractility by suppressing reactive oxygen species in isolated myocytes
Rong Lin, Xiaodong Peng, Yukun Li, Xuesi Wang, Xinmeng Liu, Xingze Jia, Chengjun Zhang, Nian Liu, Jianzeng Dong
Topics & Concepts
ContractilityReactive oxygen speciesClinical chemistryDoxorubicinMyocyteEmpagliflozinPharmacologyChemistryInternal medicineCardiologyMedicineEndocrinologyBiochemistryChemotherapyType 2 Diabetes MellitusDiabetes mellitusChemotherapy-induced cardiotoxicity and mitigationCardiovascular Function and Risk FactorsPeptidase Inhibition and Analysis